Elevated levels of IL-32 in cerebrospinal fluid of neuro-Behcet disease: Correlation with NLRP3 inflammasome

被引:9
作者
Hamzaoui, Kamel [1 ,4 ]
Borhani-Haghighi, Afshin [2 ]
Ben Dhifallah, Imen [3 ]
Hamzaoui, Agnes [1 ,4 ]
机构
[1] El Manar Tunis Univ, Fac Med Tunis, Dept Basic Sci, Dept Sci Histol Immunol & Cell Biol, Tunis, Tunisia
[2] Shiraz Univ Med Sci, Clin Neurol Res Ctr, Shiraz, Iran
[3] Univ Tunis El Manar, Pasteur Inst Tunis, Lab Clin Virol, Tunis, Tunisia
[4] Tunis El Manar Univ, Hosp A Mami, Med Fac Tunis, Dept Resp Dis,Res Lab 19SP02 Chron Pulm Pathol Ge, Pavillon B, Tunis, Ariana, Tunisia
关键词
Neuro-Behcet disease; IL-32; NLRP3; Inflammasome; CSF; INTERLEUKIN-32; EXPRESSION; MULTIPLE-SCLEROSIS; DENDRITIC CELLS; MANAGEMENT; CYTOKINES; SUBSETS; EPIDEMIOLOGY; ASSOCIATION; ACTIVATION; CASPASE-1;
D O I
10.1016/j.jneuroim.2022.577820
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interleukin-32 (IL-32) is a pro-inflammatory cytokine that induces other cytokines involved in inflammation, including tumour necrosis factor (TNF)-alpha, IL-6 and IL-1 beta. The objective of this study was to evaluate IL-32, NLRP3 inflammasome, IL-1 beta, IL-6, IL-17A, TNF-a, IL-10 and IL-37 in cerebrospinal fluid (CSF) and paired serum samples of patients with neuro-Behcet disease (NBD) by ELISA, RT-PCR and Western blotting analysis. A receiver operating characteristic (ROC) curve was employed to explore of the predictive value of IL-32 levels. IL 32, IL-1 beta, IL-6, IL-17 and TNF-alpha, were highly expressed in CSF of NBD and multiple sclerosis (MS) patients contrasting with their low levels in patients with noninflammatory neurological diseases (NIND) and Headache attributed to BD (HaBD). IL-32 and NLRP3 inflammasome in NBD, correlate significantly with CRP and ESR. IL 32 should be studied further as potential BD biomarker of inflammation in NBD.
引用
收藏
页数:11
相关论文
共 67 条
  • [1] Disturbed Th17/Treg balance, cytokines, and miRNAs in peripheral blood of patients with Behcet's disease
    Ahmadi, Majid
    Yousefi, Mehdi
    Abbaspour-Aghdam, Sanaz
    Dolati, Sanam
    Aghebati-Maleki, Leili
    Eghbal-Fard, Shadi
    Khabbazi, Alireza
    Rostamzadeh, Davood
    Alipour, Shahriar
    Shabani, Mahdi
    Nouri, Mohammad
    Babaloo, Zohreh
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (04) : 3985 - 3994
  • [2] Interleukin-6 in neuro-Behcet's disease: Association with disease subsets and long-term outcome
    Akman-Demir, Guelsen
    Tuezuen, Erdem
    Icoez, Sema
    Yesilot, Niluefer
    Yentuer, Sibel P.
    Kuertuencue, Murat
    Mutlu, Melike
    Saruhan-Direskeneli, Gueher
    [J]. CYTOKINE, 2008, 44 (03) : 373 - 376
  • [3] Neuro-Behcet's disease: epidemiology, clinical characteristics, and management
    Al-Araji, Adnan
    Kidd, Desmond P.
    [J]. LANCET NEUROLOGY, 2009, 8 (02) : 192 - 204
  • [4] The role of Interleukin-32 in autoimmunity
    Albuquerque, Rafael
    Komsi, Elina
    Starskaia, Inna
    Ullah, Ubaid
    Lahesmaa, Riitta
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2021, 93 (02)
  • [5] Management of Behcet's disease
    Alibaz-Oner, Fatma
    Sawalha, Amr H.
    Direskeneli, Haner
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2018, 30 (03) : 238 - 242
  • [6] Behcet's disease: A comprehensive review with a focus on epidemiology, etiology and clinical features, and management of mucocutaneous lesions
    Alpsoy, Erkan
    [J]. JOURNAL OF DERMATOLOGY, 2016, 43 (06) : 620 - 632
  • [7] The Cerebrospinal Fluid Presentations of Neuro-Behcet Disease, A Way to Know the Ethiopathogenesis and Improve Armamentarium
    Banerjee, Shubhasree
    Hamzoui, Kamel
    Safari, Anahid
    Borhani-Haghighi, Afshin
    [J]. IRANIAN JOURNAL OF IMMUNOLOGY, 2021, 18 (03) : 170 - 178
  • [8] TNF-α protein synthesis inhibitor restores neuronal function and reverses cognitive deficits induced by chronic neuroinflammation
    Belarbi, Karim
    Jopson, Timothy
    Tweedie, David
    Arellano, Carla
    Luo, Weiming
    Greig, Nigel H.
    Rosi, Susanna
    [J]. JOURNAL OF NEUROINFLAMMATION, 2012, 9
  • [9] Cerebrospinal fluid IL-10 as an early stage discriminative marker between multiple sclerosis and neuro-Behcet disease
    Belghith, Meriam
    Bahrini, Khadija
    Kchaou, Mariem
    Maghrebi, Olfa
    Belal, Samir
    Barbouche, Mohamed Ridha
    [J]. CYTOKINE, 2018, 108 : 160 - 167
  • [10] Ben Dhifallah I, 2019, IRAN J IMMUNOL, V16, P299, DOI [10.22034/IJI.2019.80281, 10.22034/iji.2019.80281]